Product NDC: | 54868-5809 |
Proprietary Name: | SELZENTRY |
Non Proprietary Name: | Maraviroc |
Active Ingredient(s): | 300 mg/1 & nbsp; Maraviroc |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54868-5809 |
Labeler Name: | Physicians Total Care, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022128 |
Marketing Category: | NDA |
Start Marketing Date: | 20071219 |
Package NDC: | 54868-5809-0 |
Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (54868-5809-0) |
NDC Code | 54868-5809-0 |
Proprietary Name | SELZENTRY |
Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (54868-5809-0) |
Product NDC | 54868-5809 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Maraviroc |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20071219 |
Marketing Category Name | NDA |
Labeler Name | Physicians Total Care, Inc. |
Substance Name | MARAVIROC |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | CCR5 Co-receptor Antagonist [EPC],Chemokine Co-receptor 5 Antagonists [MoA] |